Clinical Trial Update: Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC [Phase 3]

View source ↗

Summary

Phase 3 infant safety and immunogenicity trial of the MVA-BN smallpox vaccine for monkeypox vaccination in the Democratic Republic of Congo is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: Jean-Pierre Van geertruyden | Conditions: Mpox (Monkeypox), Vaccination | Phase 3 | Status: RECRUITING